| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Simply put, we`re transforming the aging experience so people live longer, healthier lives. By focusing on each person`s abilities and strengths–rather than their limitations–we believe we can impact the healthspan of older adults. Ignited by a passion to inspire older adults to live healthy, meaningful lives, we reach out with our ministries which include: independent and assisted living, rehabilitation, memory support and services including home care, adult day, home-delivered meals, hospice and transportation. As a nonprofit organization guided by Christian compassion, we were founded than 66 years ago as a place for aging Methodist ministers and their spouses to call home. Today, our services are delivered by 1,300 part- and full-time passionate team members throughout the state with a focus on creating healthier and longer lives.
Pyng Medical Corporation is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mulberry Grove is a Statham, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Harrington Health is a Wichita, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.